Separately, Zacks Investment Research downgraded Vitamin Shoppe from a buy rating to a hold rating in a research note on Friday, November 8th.
Vitamin Shoppe stock traded up $0.02 during trading on Thursday, hitting $6.49. The stock had a trading volume of 156,180 shares, compared to its average volume of 315,902. Vitamin Shoppe has a 1 year low of $3.32 and a 1 year high of $8.26. The company has a quick ratio of 0.21, a current ratio of 1.16 and a debt-to-equity ratio of 2.34. The stock’s 50 day moving average is $6.50 and its two-hundred day moving average is $5.44. The stock has a market cap of $156.40 million, a price-to-earnings ratio of 24.96 and a beta of 1.59.
Vitamin Shoppe Company Profile
Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.
Further Reading: Market Indexes
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.